Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • What we do and who we do it for | Pegasus

    March 18, 2016 | Inspiring Healthy Decisions, Integrated communications, Jo Spadaccino, Lisa Bradley, Pegasus, Pegasus showreel, Simon Hackett, This is Pegasus, ThisIsPegasus 

    We’ve built a new type of health communications consultancy. One that believes in a ‘health first, sector second’ approach. One that connects with every stakeholder. One that blends traditional, digital and social. One that creates all of its content in-house. One that’s transparent and measurable.

    Why? Because health conversations are happening everywhere, all of the time. Every day we all make decisions that impact on the quality of our own, and often other people’s, health. From the food we eat, the products we put on our skin, the medicines we take or the routines we create to prevent or manage illness. We might be a healthcare professional, a policy maker, a businessman, a patient, a parent or a combination of all these. We could be in a doctor’s surgery, at home, in the gym, or on the go. Whoever we are, wherever we are, and whatever we are doing, the ability to make healthy decisions, consciously or not, will benefit us as individuals and beyond.

    This is a new approach to health communications.

    This is Pegasus.

    Find out more at info@thisispegasus.co.uk or by calling +44 (0) 1273 712 000.

    https://youtu.be/pQATXGemj_0

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Research Partnership and Janssen are 2017-18 BOBI Awards finalists

    We are delighted to announce that an entry submitted by Research Partnership with Janssen has been selected as a finalist in the Best Business Impact category at this year’s BOBI...

    Portfolio analysis: Making Go/No-Go decisions to optimise the portfolio

    Tuesday 20th March 2018 11:00 EST / 16:00 GMT / 17:00 CEST

    PMRC New Jersey round up 2018

    Earlier this month, Directors Tom Nolte and Melinda Shorr attended the Pharmaceutical Market Research Conference in Newark, New Jersey

    Bringing sufferers out of the shadows – Reducing the emotional impact of living with Atopic Dermatitis

    You can probably remember at least one of your friends in school who was always scratching and suffered from red, scaly skin rashes, perhaps on their elbows or backs of...

    Good intentions, bad habits: Reforming mental healthcare in Latin America and the Caribbean

    In the second of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Latin America and the Caribbean

    How we applied user-led design thinking in the ER setting to improve patient care

    The challengeOur client needed to identify the key delivery-device attributes for an antibiotic topical treatment used to combat a group of infections typically affecting young children. Current treatment is a...

    Research conducted by Research Partnership published in leading medical journal

    Findings from a study conducted by Research Partnership have recently been published in the ‘Supportive Care in Cancer’ journal

    Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist

    Hiding between the lines of any company’s ledgers is an intangible asset, invisible to most auditors, but with the potential to have a very real impact on bottom line. Pharma...

    Webcast: Rich in potential – Exploring the opportunity for nutritionals in emerging markets

    Watch the webcast: http://bit.ly/2oTpzFjA shift to preventative health has seen nutritionals emerge as a rapidly developing area in recent years. But while growth begins to level off in more established territories,...

    A researcher’s guide to Key Driver Analysis

    Research Manager Kayleigh Simpson explores how Key Driver Analysis can be used to answer key business